GlaxoSmithKline Biologicals SA based in , BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-05-16 ✅ Patent 12,186,389 granted on 2025-01-07

US20240156949A1

Human necessities

Nucleic acid base vaccine against emerging SARS-CoV-2 variants

#2 | 2021-05-27 ✅ Patent 11,957,749 granted on 2024-04-16

US20210154290A1

Human necessities

Hepatitis B immunization regimen and compositions

#3 | 2019-01-31 ✅ Patent 10,350,283 granted on 2019-07-16

US20190030154A1

Human necessities

Method for preventing or treating infection

#4 | 2018-12-20 ✅ Patent 10,351,582 granted on 2019-07-16

US20180362560A1

Chemistry; metallurgy

Pegylated imidazoquinolines

#5 | 2018-09-20 ✅ Patent 10,364,273 granted on 2019-07-30

US20180265551A1

Chemistry; metallurgy

Cytomegalovirus antigens

#6 | 2018-09-06 ✅ Patent 10,279,033 granted on 2019-05-07

US20180250389A9

Human necessities

VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

#7 | 2018-03-15 ✅ Patent 10,441,648 granted on 2019-10-15

US20180071378A1

Human necessities

antigenic composition

#8 | 2018-01-11 ✅ Patent 10,336,794 granted on 2019-07-02

US20180009852A1

Chemistry; metallurgy

Immunogenic bacterial vesicles with outer membrane proteins

#9 | 2018-01-04 ✅ Patent 10,150,952 granted on 2018-12-11

US20180002679A1

Chemistry; metallurgy

Compositions and methods for protein glycosylation

#10 | 2017-12-28 ✅ Patent 10,167,321 granted on 2019-01-01

US20170369532A1

Chemistry; metallurgy

Cytomegalovirus antigens and uses thereof

#11 | 2017-12-07 ✅ Patent 10,172,928 granted on 2019-01-08

US20170348408A1

Human necessities

Purification of streptococcal capsular polysaccharide

#12 | 2017-12-07 ✅ Patent 10,226,524 granted on 2019-03-12

US20170348407A1

Human necessities

proteins and nucleic acids

#13 | 2017-11-30 ✅ Patent 10,195,263 granted on 2019-02-05

US20170340720A1

Human necessities

Compositions for immunising against

#14 | 2017-11-09 ✅ Patent 10,287,322 granted on 2019-05-14

US20170320916A1

Chemistry; metallurgy

Complexes of cytomegalovirus proteins

#15 | 2017-08-31 ✅ Patent 10,188,719 granted on 2019-01-29

US20170246285A1

Human necessities

Conjugation of capsular saccharides

#16 | 2017-08-10 ✅ Patent 10,307,374 granted on 2019-06-04

US20170224616A1

Human necessities

Oil-in-water emulsions that contain nucleic acids

#17 | 2017-07-20 ✅ Patent 10,183,074 granted on 2019-01-22

US20170202960A1

Human necessities

Cationic oil-in-water emulsions

#18 | 2017-07-13 ✅ Patent 10,105,430 granted on 2018-10-23

US20170196961A1

Human necessities

Method for preventing or treating infection

#19 | 2017-07-13 ✅ Patent 10,485,865 granted on 2019-11-26

US20170196960A1

Human necessities

Method and compositions

#20 | 2017-05-25 ✅ Patent 10,328,140 granted on 2019-06-25

US20170143816A1

Human necessities

Mutant staphylococcal antigens

#21 | 2017-03-09 ✅ Patent 10,286,053 granted on 2019-05-14

US20170065697A1

Human necessities

Compositions and methods

#22 | 2017-03-09 ✅ Patent 9,655,958 granted on 2017-05-23

US20170065696A9

Human necessities

Method for preventing or treating infection

#23 | 2016-12-29 ✅ Patent 10,046,048 granted on 2018-08-14

US20160375132A1

Human necessities

Homogenous suspension of immunopotentiating compounds and uses thereof

#24 | 2016-12-08 ✅ Patent 9,981,031 granted on 2018-05-29

US20160354457A1

Human necessities

Injectable vaccines against multiple meningococcal serogroups

#25 | 2016-10-20 ✅ Patent 10,064,932 granted on 2018-09-04

US20160303215A1

Human necessities

Integration of meningococcal conjugate vaccination

#26 | 2016-10-20 ✅ Patent 10,195,262 granted on 2019-02-05

US20160303213A1

Human necessities

Prevention of infections by glycoprotein vaccines synthesized in

#27 | 2016-09-08 ✅ Patent 10,238,733 granted on 2019-03-26

US20160256541A1

Human necessities

Cationic oil-in-water emulsions

#28 | 2016-08-25 ✅ Patent 10,279,033 granted on 2019-05-07

US20160243219A1

Human necessities

Vaccine comprising capsular polysaccharide conjugates

#29 | 2016-07-28 ✅ Patent 10,098,949 granted on 2018-10-16

US20160213776A1

Human necessities

Adsorption of immunopotentiators to insoluble metal salts

#30 | 2016-07-14 ✅ Patent 10,179,167 granted on 2019-01-15

US20160199476A1

Human necessities

Developments in meningococcal outer membrane vesicles

#31 | 2016-06-30 ✅ Patent 9,750,794 granted on 2017-09-05

US20160184420A1

Human necessities

Compositions and methods

#32 | 2016-06-16 ✅ Patent 9,764,020 granted on 2017-09-19

US20160166673A1

Human necessities

proteins and nucleic acids

#33 | 2016-03-10 ✅ Patent 9,987,345 granted on 2018-06-05

US20160067327A1

Human necessities

OMV vaccines

#34 | 2016-02-25 ✅ Patent 9,839,686 granted on 2017-12-12

US20160051667A1

Human necessities

Conjugation of type 8 capsular polysaccharides

#35 | 2015-12-31 ✅ Patent 10,287,330 granted on 2019-05-14

US20150376245A1

Chemistry; metallurgy

Methods and compositions relating to CRM197

#36 | 2015-12-17 ✅ Patent 9,700,605 granted on 2017-07-11

US20150359863A1

Human necessities

Vaccine comprising an oil in water emulsion

#37 | 2015-08-20 ✅ Patent 9,655,958 granted on 2017-05-23

US20150231224A1

Human necessities

Method for preventing or treating infection

#38 | 2015-07-23 ✅ Patent 9,926,344 granted on 2018-03-27

US20150203542A1

Chemistry; metallurgy

Stabilised proteins for immunising against

#39 | 2015-05-07 ✅ Patent 9,499,639 granted on 2016-11-22

US20150126727A1

Chemistry; metallurgy

LPS extraction process

#40 | 2015-04-16 ✅ Patent 10,124,051 granted on 2018-11-13

US20150104479A1

Human necessities

Meningococcus serogroup X conjugate

#41 | 2014-08-07 ✅ Patent 9,636,410 granted on 2017-05-02

US20140220083A1

Human necessities

Cationic oil-in-water emulsions

#42 | 2014-07-24 ✅ Patent 9,717,788 granted on 2017-08-01

US20140205652A1

Human necessities

Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant

#43 | 2014-06-26 ✅ Patent 9,795,663 granted on 2017-10-24

US20140178423A1

Human necessities

Compositions and methods

#44 | 2014-04-17 ✅ Patent 9,623,114 granted on 2017-04-18

US20140105992A1

Human necessities

Vaccine

#45 | 2014-01-30 ✅ Patent 9,540,416 granted on 2017-01-10

US20140030318A1

Chemistry; metallurgy

Purification process

#46 | 2014-01-16 ✅ Patent 10,357,568 granted on 2019-07-23

US20140017285A1

Human necessities

Adjuvant nanoemulsions with phospholipids

#47 | 2014-01-16 ✅ Patent 10,286,056 granted on 2019-05-14

US20140017279A1

Human necessities

Adjuvant nanoemulsions with crystallisation inhibitors

#48 | 2013-10-24 ✅ Patent 9,730,992 granted on 2017-08-15

US20130280289A1

Human necessities

antigenic composition

#49 | 2013-07-11 ✅ Patent 9,770,463 granted on 2017-09-26

US20130177640A1

Human necessities

Delivery of RNA to different cell types

#50 | 2013-07-11 ✅ Patent 9,801,897 granted on 2017-10-31

US20130177639A1

Human necessities

Delivery of RNA to trigger multiple immune pathways

#51 | 2012-09-27 ✅ Patent 9,353,160 granted on 2016-05-31

US20120244189A1

Chemistry; metallurgy

Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof

#52 | 2012-09-20 ✅ Patent 9,950,062 granted on 2018-04-24

US20120237546A1

Human necessities

Compounds and compositions as TLR activity modulators

#53 | 2012-07-12 ✅ Patent 9,341,623 granted on 2016-05-17

US20120178185A1

Physics

Immunodiffusion assay for influenza virus

#54 | 2012-02-02 ✅ Patent 9,718,863 granted on 2017-08-01

US20120027788A1

Chemistry; metallurgy

Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof

#55 | 2010-12-23 ✅ Patent 8,703,148 granted on 2014-04-22

US20100322959A1

Human necessities

Immunogenic composition

#56 | 2010-12-23 ✅ Patent 9,803,030 granted on 2017-10-31

US20100322958A1

Chemistry; metallurgy

Modified saccharides

#57 | 2010-12-02 ✅ Patent 8,933,218 granted on 2015-01-13

US20100303852A1

Human necessities

Conjugation process for PNAG and a carrier protein

#58 | 2010-11-04 ✅ Patent 8,481,700 granted on 2013-07-09

US20100280105A1

Chemistry; metallurgy

Detection of mage-A expression

#59 | 2010-06-10 ✅ Patent 10,195,264 granted on 2019-02-05

US20100143418A1

Human necessities

Immunising against meningococcal serogroup Y using proteins

#60 | 2010-06-10 ✅ Patent 8,858,955 granted on 2014-10-14

US20100143399A1

Human necessities

Process for manufacturing vaccines

#61 | 2009-07-16 ✅ Patent 9,782,467 granted on 2017-10-10

US20090182128A1

Human necessities

Capsular polysaccharide solubilisation and combination vaccines

#62 | 2009-07-16 ✅ Patent 9,782,466 granted on 2017-10-10

US20090181049A1

Human necessities

Capsular polysaccharide solubilisation and combination vaccines

#63 | 2007-04-12 ✅ Patent 10,272,147 granted on 2019-04-30

US20070082014A1

Human necessities

Injectable vaccines against multiple meningococcal serogroups

AssigneeID:

467344 ⎘